Candriam Equities L Biotech.C-H EUR Acc/  LU1120766206  /

Fonds
NAV6/20/2024 Chg.+1.7200 Type of yield Investment Focus Investment company
197.9000EUR +0.88% reinvestment Equity Candriam 

Funds documents

Date Document Year Language Filesize
6/23/2024 Public WebStation Live Factsheet 2024 English -
6/3/2024 Prospectus 2024 English 3,663.84 KB
6/3/2024 Prospectus 2024 German 5,520.88 KB
3/1/2024 PRIIP Key Information Document 2024 German 269.02 KB
12/31/2023 Account statment 2023 English 5,416.37 KB
12/31/2023 Account statment 2023 German 4,732.66 KB
6/30/2023 Semi-annual report 2023 English 1,982.78 KB
6/30/2023 Semi-annual report 2023 German 2,086.39 KB
12/1/2022 Key Investor Information 2022 German 362.40 KB